Van beleggers
voor beleggers
desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?

Ontvang nu dagelijks onze kooptips!

word abonnee

MOR103 (PerC6 inside) PHASE I

181 Posts
Pagina: «« 1 ... 5 6 7 8 9 10 | Laatste | Omlaag ↓
  1. flosz 21 september 2012 11:34
    MorphoSys's MOR103 Antibody Demonstrates Excellent Safety and Efficacy in Rheumatoid Arthritis Patients
    www.morphosys.com/sites/default/files...

    MorphoSys to Host Conference Call on Clinical Trial Results of MOR103 in Rheumatoid Arthritis
    09/21/2012 - Conference Call and Webcast: Clinical Trial Results of MOR103 in Rheumatoid Arthritis
    Today at 3:00 p.m. CET (2:00 p.m. BST, 9:00 a.m. EDT), the Management Board of MorphoSys AG will host a public conference call and webcast to present information on the results of the clinical phase 1b/2a trial of MorphoSys's proprietary antibody MOR103 in patients with rheumatoid arthritis, which was announced yesterday.
    www.media-server.com/m/p/wbc89y57
181 Posts
Pagina: «« 1 ... 5 6 7 8 9 10 | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Indices

AEX 910,59 +0,71%
EUR/USD 1,0770 0,00%
FTSE 100 8.433,76 +0,63%
Germany40^ 18.773,50 +0,00%
Gold spot 2.360,09 -0,03%
NY-Nasdaq Composite 16.340,87 -0,03%

Stijgers

Accsys
+5,43%
CM.COM
+2,92%
NX FIL...
+2,63%
RANDST...
+2,61%
ForFar...
+2,43%

Dalers

Kendrion
-2,99%
UMG
-2,95%
Alfen ...
-2,63%
EBUSCO...
-2,29%
VIVORY...
-1,85%

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links